Coronavirus: US hospitals to use blood from Covid-19 survivors to treat patients for first time
Critically ill coronavirus patients in the US could be treated with the plasma of survivors under FDA emegency measures
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Hospitals across the US can begin using plasma to treat coronavirus patients following emergency protocols outlined by the Food and Drug Administration (FDA) on Tuesday.
Doctors hope that antibodies in survivors’ blood can be used to treat coronavirus patients who are in a critical condition.
Across the US there are now almost 55,000 confirmed cases of the virus, with at least 784 deaths.
Andrew Cuomo, the governor of New York - and the state at the centre of the outbreak in the US - announced on Tuesday that trials of the practice would commence this week.
“There have been tests that show when a person is injected with the antibodies, that then stimulates and promotes their immune system against that disease”, he said.
Mr Cuomo, who described the treatment as showing “promise”, added that the treatment was being trialled on the most serious cases.
An acceleration of confirmed cases in New York State alone has resulted in 25,665 cases - almost 7 per cent of the world total. In addition, 210 have died in the state as of Tuesday.
According to an NBC News report, China began using blood plasma on coronavirus patients with signs that it could be an effective method to treat the disease.
The practice was also used to lessen the symptom and reduce hospitalisation during the SARS and Ebola outbreaks.
Dr. Arturo Casadevall, an infectious disease expert at the Johns Hopkins University’s school of public health, told The Associated Press: “We won’t know until we do it, but the historical evidence is encouraging”.
Under the emergency measures introduced by the FDA, doctors must request permission to treat critically ill coronavirus patients on a case-by-case basis and will be reserved for those at risk of death.
The FDA statement added that whilst convalescent plasma have been proven effective in treating previous diseases, it’s use against coronavirus was still to be determined through clinical trials before being rolled-out across the US.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments